NCT00901784View on ClinicalTrials.gov

Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

September 30, 2001

Study Completion Date

October 31, 2001

Conditions
Healthy
Interventions
DRUG

Topiramate

25mg Tablets

Trial Locations (1)

H4R 2N6

MDS Pharina Services (Clinical Research Center), Saint Laurent, Québec

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00901784 - Bioequivalence Study of Topiramate Tablets 25mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter